MedPath

Digital Integrative Medicine Intervention Shows Promise in Reducing Cancer Treatment Symptoms

A randomized clinical trial demonstrates that a digital integrative medicine intervention, IM@Home, significantly improves fatigue and comorbid symptoms like anxiety and depression in cancer patients undergoing active treatment. The study also found a reduction in acute healthcare utilization, suggesting potential cost savings and improved patient care.

Patients undergoing active cancer treatment often experience a significant burden from symptoms such as fatigue, anxiety, and depression, which can lead to disruptions in treatment and increased acute care utilization. Recognizing the need for improved symptom management, a digital integrative medicine intervention, IM@Home, was developed to offer mind-body therapies and exercise programs to patients from their homes.
A single-blind, basket randomized controlled trial (RCT) was conducted to evaluate the effect of IM@Home on fatigue, comorbid symptoms, and acute healthcare utilization. The trial involved 200 patients, with 99 randomized to the IM@Home group and 101 to an enhanced usual care (EUC) control group. The IM@Home program included synchronous (live) classes such as yoga, fitness, meditation, and tai chi, delivered via Zoom.
Results showed that IM@Home participants experienced greater improvements in fatigue severity scores compared to the EUC group. Additionally, IM@Home participants had promising reductions in symptom distress, anxiety, and depression. The study also found that the IM@Home group had fewer emergency department (ED) visits and hospitalizations, with those hospitalized spending fewer days in the hospital.
The study contributes to the limited research on digital medicine interventions for symptom management in cancer care, demonstrating the potential of such interventions to improve patient outcomes and reduce healthcare costs. However, the study acknowledges limitations, including its single-center design and the need for future research to include more diverse populations and evaluate the long-term effectiveness of digital mind-body therapies.
In conclusion, the IM@Home program represents a promising approach to improving the well-being of cancer patients undergoing active treatment, with the potential to reduce symptom burden and acute healthcare utilization. Future adequately powered trials are needed to confirm these findings and further explore the benefits of digital health interventions in cancer care.
Subscribe Icon

Stay Updated with Our Daily Newsletter

Get the latest pharmaceutical insights, research highlights, and industry updates delivered to your inbox every day.

Highlighted Clinical Trials

A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer

NCT05053230RecruitingNot Applicable
Memorial Sloan Kettering Cancer Center
Posted 9/20/2021

Related Topics

RelieVRx Shows Significant Pain Relief in High-Impact Chronic Pain Patients

A secondary analysis of a large RCT showed AppliedVR's RelieVRx significantly reduced pain intensity and interference in high-impact chronic pain (HICP) patients.
70% of HICP patients were reclassified as lower-impact chronic pain (LICP) patients post-treatment, with 67% maintaining this status after 12 months.

Photopharmics' LIGHT-PD Trial Shows Promise for Remote Parkinson's Studies

Photopharmics' Phase 3 LIGHT-PD trial demonstrates the feasibility of fully remote, home-based studies for Parkinson's disease patients.
The trial assesses Celeste, a light-based therapy device, aiming to regulate circadian rhythms and alleviate motor and non-motor symptoms.

Digital Coaching Service Shows Promise in Managing Hypertension and Depression Comorbidity

A randomized control trial in Northumbria assesses the feasibility of using Holly Health's digital coaching service for patients with hypertension and depression/anxiety.
After 12 weeks, 64% of patients found the service useful, and 69% reported benefiting from it, with 92% finding it acceptable as a digital health intervention.

Digital, Decentralized Trial Shows Feasibility of Exercise Therapy for Cancer Patients

A digital, decentralized clinical trial (DPEx) demonstrated the feasibility of remotely delivered, supervised exercise therapy for cancer patients.
The study utilized wearable technology and video conferencing to monitor patients' adherence and safety during at-home exercise sessions.

Multidisciplinary Therapy Improves Outcomes in Functional Movement Disorders

A randomized clinical trial demonstrates that integrating physiotherapy and cognitive-behavioral therapy improves symptoms in patients with functional movement disorders.
Patients receiving the multidisciplinary approach showed a 50% reduction in motor symptom severity at a 5-month follow-up compared to the control group.

Digital Medicine Support Models Tested for Alcohol Use Disorder

A 12-month randomized controlled trial evaluated the effectiveness of various digital medicine support models in reducing heavy drinking days and improving quality of life among individuals with mild-to-moderate Alcohol Use Disorder (AUD). The study found significant reductions in heavy drinking days across all groups, with the clinically integrated group showing the most substantial decrease. However, no significant differences in effectiveness were observed among the self-monitored, peer-supported, and clinically integrated groups. The study highlights the potential of digital health interventions in addressing AUD, emphasizing the importance of patient preferences and the need for further research to optimize these interventions.

Comprehensive Digital System Reduces Symptom Burden in Cancer Patients Undergoing Chemotherapy

A randomized clinical trial evaluated the efficacy of a multicomponent digital intervention, Symptom Care at Home (SCH), in reducing symptom burden among cancer patients undergoing chemotherapy.
The complete SCH intervention, which includes automated self-management coaching and nurse practitioner (NP) follow-up with decision support, significantly reduced symptom burden compared to individual components alone.

Decentralized Clinical Trials Show Promise in Remote Data Collection and Patient-Centric Research

A Phase I pharmacokinetic trial demonstrates the feasibility and benefits of decentralized clinical trials (DCTs) for remote data collection.
DCTs improve patient access, representation, and enrollment, while also enhancing the speed and quality of data collection.

Paradoxical Intervention: A Novel Strategy to Overload Cancer Cells

Researchers are initiating a clinical trial using a 'paradoxical intervention' strategy to treat advanced colorectal cancer by overstimulating oncogenic signaling.
The approach involves LB-100, a PP2A inhibitor, to stress cancer cells, followed by adavosertib, a WEE1 inhibitor, to prevent DNA damage repair.

Digital Care Program Shows Comparable Effectiveness to In-Person Physiotherapy for Chronic Low Back Pain

A randomized controlled trial comparing a digital care program (DCP) with conventional in-person physiotherapy for chronic low back pain (CLBP) found both interventions equally effective. The study involved 140 participants, showing similar improvements in disability and pain levels, with high adherence and satisfaction rates. Notably, the digital group had lower dropout rates, suggesting the potential of digital interventions to democratize healthcare access.

Reference News

[1]
Randomized clinical trial of a digital integrative medicine intervention among patients ... - Nature
nature.com · Jan 14, 2025

Cancer patients on active treatment face significant symptom burdens, leading to increased acute care use. A digital, sy...

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy